RESUMO
In the present work, hybrid microgels based on chitosan and SiO2 nanoparticles (NPs) were synthesized. Both chitosan and the SiO2 NPs were submitted to chemical modification reactions to having vinyl groups incorporated into their structures. The microgels were synthesized by emulsion polymerization. SEM analysis indicated a high dispersity of diameter for the microgels, ranging between (18.7⯱â¯12.3) µm for the samples without SiO2-VTS and (11.3⯱â¯8.07) µm for the microgels with SiO2-VTS. The material showed pH-responsiveness, especially in acidic pHs. The longest release lasted 45â¯min and large amounts of drugs were released as soon as the material was added to the release medium. It is interesting for oral drug delivery systems, especially for gastric wound treatment. The fast release of high amounts of drugs promotes an immediate relief of the pain and the following controlled release allows the gradual recovery of the damaged area.
Assuntos
Quitosana/química , Sistemas de Liberação de Medicamentos , Microgéis/química , Gastropatias/tratamento farmacológico , Vitamina B 12/farmacologia , Administração Oral , Sobrevivência Celular/efeitos dos fármacos , Quitosana/administração & dosagem , Células HT29 , Humanos , Concentração de Íons de Hidrogênio , Microgéis/administração & dosagem , Nanopartículas/administração & dosagem , Nanopartículas/química , Tamanho da Partícula , Silanos/administração & dosagem , Silanos/química , Dióxido de Silício/administração & dosagem , Dióxido de Silício/química , Propriedades de Superfície , Vitamina B 12/administração & dosagem , Vitamina B 12/químicaRESUMO
Magnetic microgels based on chitosan, modified with glycidyl methacrylate (GMA) and activated with folic acid (FA), and cobalt ferrite nanoparticles, modified with GMA (GMACoFe2O4), were synthesized by emulsion polymerization. The size of the round-shaped microgels, with and without GMACoFe2O4, ranged from (1.62 ± 0.38) µm to (1.71 ± 0.61) µm, respectively. Their release behavior was evaluated in the presence and absence of a magnetic field (MF), using vitamin-B12 as a model drug. In the absence of MF, at pH 7.4, a fast release was observed, reaching the equilibrium after 30 min. In the MF presence, the alignment of the chains to it promoted an initial fast release, followed by a more controlled one, lasting for 50 min at pH 7.4. This type of release is attractive for the treatment of gastric wounds, which is improved by the presence of FA, conferring anti-oxidative and anti-secretory properties to the microgels.
Assuntos
Quitosana/química , Portadores de Fármacos/química , Liberação Controlada de Fármacos , Magnetismo , Microgéis/química , Nanopartículas/química , Vitamina B 12/metabolismo , Complexo Vitamínico B/metabolismoRESUMO
The aim of this study was to synthesize and characterize mesoporous materials SBA-15 and SBA-15 modified with 3-(methacryloxy)-propyl-trimethoxysilane (MPS) to be used as inorganic filler in restorative dental composites and adhesives, and evaluate the main physical-chemical properties of the resulting material. The SBA-15 and SBA-15/MPS were characterized by FTIR, BET and X-Ray and combined with TEGDMA, bis-GMA and commercial spherical silica to produce dental composites. Afterwards, the mesoporous materials were combined with TEGDMA, bis-GMA and HEMA to make adhesives. To compare the results, composites and adhesives containing only commercial spherical silica were investigated. Some physical-chemical properties such as degree of conversion (DC), flexural strength (FS) and modulus (FM), water sorption and solubility (Wsp and Wsl), specific area (BET), and the leachable components were evaluated. The SBA-15/MPS can be used to prepare dental restorative materials, with some foreseeable advantages compared with pure SBA-15 dental materials and with improved properties compared with commercial spherical silica dental materials. An important improvement was that the dental materials based on modified SBA-15 presented a reduction of approximately 60% in leaching of unreacted monomers extracted by solvent compared to the control group.